A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
Autorzy:
Smith AL; Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Eiken AP; Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Skupa SA; Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Moore DY; Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Umeta LT; Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Smith LM; Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA. Lyden ER; Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA. D'Angelo CR; Division of Hematology and Oncology, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Kallam A; Division of Hematology and Oncology, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. Vose JM; Division of Hematology and Oncology, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. KutateladzeTG; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA. El-Gamal D; Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
The ZZ domain of HERC2 is a receptor of arginylated substrates.
Autorzy:
Tencer AH; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, 80045, USA. Liu J; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, 80045, USA. Zhu J; Department of Translational Oncology, St. Marianna University Graduate School of Medicine, 2‑16‑1, Sugao, Miyamae‑ku, Kawasaki, 216‑8511, Japan. Burkholder NT; Department of Biochemistry and Biophysics, The University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA. Zhang Y; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, 80045, USA. Wu W; Department of Translational Oncology, St. Marianna University Graduate School of Medicine, 2‑16‑1, Sugao, Miyamae‑ku, Kawasaki, 216‑8511, Japan. Strahl BD; Department of Biochemistry and Biophysics, The University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA. Ohta T; Department of Translational Oncology, St. Marianna University Graduate School of Medicine, 2‑16‑1, Sugao, Miyamae‑ku, Kawasaki, 216‑8511, Japan. KutateladzeTG; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, 80045, USA. tatiana.kutateladze@cuanschutz.edu.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Apr 11; Vol. 12 (1), pp. 6063. Date of Electronic Publication: 2022 Apr 11.
PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron.
Autorzy:
Acharya A; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA. Pathania AS; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centre, Omaha, Nebraska, USA. Pandey K; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA. Thurman M; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA. Vann KR; Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA. KutateladzeTG; Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA. Challagundala KB; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centre, Omaha, Nebraska, USA.; The Child Health Research Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA. Durden DL; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Moores Cancer Center, UC San Diego School of Medicine, La Jolla, California, USA.; Levine Cancer Institute, Charlotte, North Carolina, USA. Byrareddy SN; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centre, Omaha, Nebraska, USA.; Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Centre, Omaha, Nebraska, USA.; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Characterization of nucleosome sediments for protein interaction studies by solid-state NMR spectroscopy.
Autorzy:
le Paige UB; Utrecht NMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, 3584 CH, Utrecht, the Netherlands. Xiang S; Utrecht NMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, 3584 CH, Utrecht, the Netherlands. Hendrix MMRM; Laboratory of Self-Organizing Soft Matter, Department of Chemical Engineering and Chemistry & Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB, Eindhoven, the Netherlands. Zhang Y; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Folkers GE; Utrecht NMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, 3584 CH, Utrecht, the Netherlands. Weingarth M; Utrecht NMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, 3584 CH, Utrecht, the Netherlands. Bonvin AMJJ; Utrecht NMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, 3584 CH, Utrecht, the Netherlands. KutateladzeTG; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Voets IK; Laboratory of Self-Organizing Soft Matter, Department of Chemical Engineering and Chemistry & Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB, Eindhoven, the Netherlands. Baldus M; Utrecht NMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, 3584 CH, Utrecht, the Netherlands. van Ingen H; Utrecht NMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, 3584 CH, Utrecht, the Netherlands.
Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets.
Autorzy:
Vann KR; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA. Pal D; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. Morales GA; SignalRx Pharmaceuticals, San Diego, CA, USA. Burgoyne AM; Division of Hematology-Oncology, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. Durden DL; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. .; SignalRx Pharmaceuticals, San Diego, CA, USA. . KutateladzeTG; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA. tatiana.kutateladze@cuanschutz.edu.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jul 21; Vol. 10 (1), pp. 12027. Date of Electronic Publication: 2020 Jul 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
The ZZ domain as a new epigenetic reader and a degradation signal sensor.
Autorzy:
Zhang Y; a Department of Pharmacology , University of Colorado School of Medicine , Aurora , CO , USA. Mi W; b Center for Epigenetics Van Andel Research Institute , Grand Rapids , MI , USA. Xue Y; c Genetics and Epigenetics Graduate Program , The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences , Houston , TX , USA. Shi X; b Center for Epigenetics Van Andel Research Institute , Grand Rapids , MI , USA. KutateladzeTG; a Department of Pharmacology , University of Colorado School of Medicine , Aurora , CO , USA.
Epigenetic countermarks in mitotic chromosome condensation.
Autorzy:
van Wely KH; a Department of Immunology and Oncology , Centro Nacional de Biotecnología/CSIC , Madrid , Spain. Mora Gallardo C; a Department of Immunology and Oncology , Centro Nacional de Biotecnología/CSIC , Madrid , Spain. Vann KR; b Department of Pharmacology , University of Colorado School of Medicine , Aurora , CO , USA. KutateladzeTG; b Department of Pharmacology , University of Colorado School of Medicine , Aurora , CO , USA.
Pokaż więcej
Źródło:
Nucleus (Austin, Tex.) [Nucleus] 2017 Mar 04; Vol. 8 (2), pp. 144-149. Date of Electronic Publication: 2017 Jan 03.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies